LAVYX
Price
$15.02
Change
-$0.41 (-2.66%)
Updated
Dec 18 closing price
RMFCX
Price
$54.22
Change
-$1.42 (-2.55%)
Updated
Dec 18 closing price
Ad is loading...

LAVYX vs RMFCX

Header iconLAVYX vs RMFCX Comparison
Open Charts LAVYX vs RMFCXBanner chart's image
Lord Abbett Fundamental Equity I
Price$15.02
Change-$0.41 (-2.66%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.22
Change-$1.42 (-2.55%)
VolumeN/A
CapitalizationN/A
LAVYX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LAVYX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LAVYX is a Hold and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 98.7B vs. LAVYX (1.94B). RMFCX pays higher dividends than LAVYX: RMFCX (1.69) vs LAVYX (0.94). LAVYX was incepted earlier than RMFCX: LAVYX (22 years) vs RMFCX (23 years). LAVYX (26.00) and RMFCX (25.00) have comparable annual turnover. RMFCX has a lower initial minimum investment than LAVYX: RMFCX (250) vs LAVYX (1000000). LAVYX annual gain was more profitable for investors over the last year : 17.19 vs. RMFCX (9.39). RMFCX return over 5 years is better than : 36.51 vs. LAVYX (33.45).
LAVYXRMFCXLAVYX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years23 years-
Gain YTD16.0608.896181%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.94B98.7B2%
Annual Yield % from dividends0.941.6956%
Returns for 1 year17.199.39183%
Returns for 3 years17.7211.57153%
Returns for 5 years33.4536.5192%
Returns for 10 years23.8458.1741%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.850.02
+2.57%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc